BRITE-338733

• Description:

  BRITE-338733 is a RecA ATPase inhibitor, with an IC50 of 4.7 µM[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H315, H319, H335

• Target:

  Bacterial

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/brite-338733.html

• Purity:

  98.93

• Solubility:

  1 M HCl : 100 mg/mL (ultrasonic) |DMSO : 10 mg/mL (ultrasonic; adjust pH to 4 with HCl)

• Smiles:

  OC1=CC=C(C)C=C1C2=NC(NC3CC(C)(C)NC(C)(C)C3)=CC(C4=CC=C(CC)O4)=C2

• Molecular Formula:

  C27H35N3O2

• Molecular Weight:

  433.59

• Precautions:

  H315, H319, H335

• References & Citations:

  [1]Sexton JZ, et al. Novel Inhibitors of E. coli RecA ATPase Activity. Curr Chem Genomics. 2010;4:34-42. Published 2010 May 26.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C, 3 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  503105-88-2